Melqart Asset Management (UK) Ltd

Position in ABVX — Abivax S.A.

CIK 1712901 London, X0

Position in ABVX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$40,944,135

+$36,495,134 QoQ

Shares Held

307,250

+831.3% QoQ

Ownership

0.352%

of shares outstanding

% of Portfolio

4.16%

of 13F equity value

Holder Rank

#41

of 302 holders

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Melqart Asset Management (UK) Ltd holds $144,610,610 across 5 Biotechnology names. ABVX ranks #2 (28.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	767,525	$65,385,454
2	ABVX	Abivax S.A. This page	307,250	$40,944,135
3	RVMD	Revolution Medicines, Inc.	121,308	$22,718,562
4	APGE	Apogee Therapeutics, Inc.	117,249	$15,562,459
5	CPRX	Catalyst Pharmaceuticals, Inc.	247,556	$0

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$40,944,135	307,250	+831.3%	Shares	Sole	2026-08-14
2025-12-31	$4,449,001	32,991	-48.6%	Shares	Sole	2026-02-17
2025-09-30	$5,446,929	64,157	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.